共 21 条
Artificial Intelligence's Impact on Drug Discovery and Development From Bench to Bedside
被引:16
作者:
Vidhya, K. S.
[1
]
Sultana, Ayesha
[2
]
Kumar, M. Naveen
[3
]
Rangareddy, Harish
[4
]
机构:
[1] Univ Visvesvaraya, Coll Engn, Bioinformat, Bangalore, India
[2] St Georges Univ, Sch Med, Pathol, St Georges, Grenada
[3] Haveri Inst Med Sci, Pharmacol, Haveri, India
[4] Haveri Inst Med Sci, Biochem, Haveri, India
关键词:
drug discovery research;
future of healthcare;
nano technology;
drug design;
artificial intelligence in healthcare;
LIPID NANOPARTICLES;
D O I:
10.7759/cureus.47486
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Artificial intelligence (AI) techniques have the potential to revolutionize drug release modeling, optimize therapy for personalized medicine, and minimize side effects. By applying AI algorithms, researchers can predict drug release profiles, incorporate patient-specific factors, and optimize dosage regimens to achieve tailored and effective therapies. This AI-based approach has the potential to improve treatment outcomes, enhance patient satisfaction, and advance the field of pharmaceutical sciences. International collaborations and professional organizations play vital roles in establishing guidelines and best practices for data collection and sharing. Open data initiatives can enhance transparency and scientific progress, facilitating algorithm validation.
引用
收藏
页数:10
相关论文